NFKB1 and cancer: While APOBEC has been implicated in drug resistance previously33,73, our study reveals a distinct mechanism by which targeted cancer therapy is actively responsible for the upregulation of APOBEC via NF-κB-mediated transcriptional induction in response to therapy.